Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 1 (2004), Issue 5 (December)

1. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
   J Clin Virol, 32(1): 33-7. [Abstract] [Full-text]
2. The large loop excision of the transformation zone cut or blend thermal artefact study: a randomized controlled trial.
   Int J Gynecol Cancer, 14(6): 1108-11. [Abstract] [Full-text]
3. A pilot study for a screening trial of cervical fluorescence spectroscopy.
   Int J Gynecol Cancer, 14(6): 1097-107. [Abstract] [Full-text]
4. Folate is associated with the natural history of high-risk human papillomaviruses.
   Cancer Res, 64(23): 8788-93. [Abstract] [Full-text]
5. Inhibited interpersonal coping style predicts poorer adherence to scheduled clinic visits in human immunodeficiency virus infected women at risk for cervical cancer.
   Ann Behav Med, 28(3): 195-202. [Abstract] [Full-text]
6. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.
   Virchows Arch, 445(6): 616-20. [Abstract] [Full-text]
7. p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.
   Virchows Arch, 445(6): 610-5. [Abstract] [Full-text]
8. Acetowhite epithelium.
   Gynecol Oncol, 95(3): 691-4. [Abstract] [Full-text]
9. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer.
   Gynecol Oncol, 95(3): 680-5. [Abstract] [Full-text]
10. Laparoscopically assisted radical vaginal hysterectomy vs. radical abdominal hysterectomy for cervical cancer: a match controlled study.
    Gynecol Oncol, 95(3): 655-61. [Abstract] [Full-text]
11. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
    Gynecol Oncol, 95(3): 646-54. [Abstract] [Full-text]
12. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
    Gynecol Oncol, 95(3): 618-23. [Abstract] [Full-text]
13. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Gynecol Oncol, 95(3): 610-7. [Abstract] [Full-text]
14. Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients.
    Gynecol Oncol, 95(3): 597-602. [Abstract] [Full-text]
15. Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa-IVa cervical cancer.
    Gynecol Oncol, 95(3): 576-82. [Abstract] [Full-text]
16. The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women.
    Gynecol Oncol, 95(3): 557-63. [Abstract] [Full-text]
17. A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?
    Gynecol Oncol, 95(3): 534-8. [Abstract] [Full-text]
18. Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth.
    Gynecol Oncol, 95(3): 523-9. [Abstract] [Full-text]
19. Apoptosis-related proteins and cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women.
    Gynecol Oncol, 95(3): 500-5. [Abstract] [Full-text]
20. Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells.
    DNA Cell Biol, 23(11): 769-76. [Abstract] [Full-text]
21. Colposcopy quality control by remote review of digitized colposcopic images.
    Am J Obstet Gynecol, 191(6): 1934-41. [Abstract] [Full-text]
22. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy.
    Am J Obstet Gynecol, 191(6): 1907-13. [Abstract] [Full-text]
23. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy.
    Radiother Oncol, 73(3): 331-7. [Abstract] [Full-text]
24. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear.
    Diagn Cytopathol, 32(1): 21-4. [Abstract] [Full-text]
25. Successful human ovarian autotransplantation to the upper arm.
    Cancer, 101(12): 2771-8. [Abstract] [Full-text]
26. Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis.
    Int J Cancer, 113(5): 712-8. [Abstract] [Full-text]
27. Is there a role for colposcopy in the follow-up of treated low grade squamous intraepithelial lesions?
    Aust N Z J Obstet Gynaecol, 44(6): 574-6. [Abstract] [Full-text]
28. Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
    Aust N Z J Obstet Gynaecol, 44(6): 514-6. [Abstract] [Full-text]
29. Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma.
    Gynecol Oncol, 96(1): 194-7. [Abstract] [Full-text]
30. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer.
    Gynecol Oncol, 96(1): 187-93. [Abstract] [Full-text]
31. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.
    Gynecol Oncol, 96(1): 173-80. [Abstract] [Full-text]
32. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Gynecol Oncol, 96(1): 168-72. [Abstract] [Full-text]
33. IGSF4 promoter methylation and expression silencing in human cervical cancer.
    Gynecol Oncol, 96(1): 150-8. [Abstract] [Full-text]
34. A clinical study of optical biopsy of the uterine cervix using a multispectral imaging system.
    Gynecol Oncol, 96(1): 119-31. [Abstract] [Full-text]
35. Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status.
    Gynecol Oncol, 96(1): 112-8. [Abstract] [Full-text]
36. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Gynecol Oncol, 96(1): 108-11. [Abstract] [Full-text]
37. Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Gynecol Oncol, 96(1): 103-7. [Abstract] [Full-text]
38. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients.
    Gynecol Oncol, 96(1): 92-102. [Abstract] [Full-text]
39. A simple method for the detection and genotyping of high-risk human papillomavirus using seminested polymerase chain reaction and reverse hybridization.
    Gynecol Oncol, 96(1): 84-91. [Abstract] [Full-text]
40. The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions.
    Br J Cancer, 91(12): 2056-62. [Abstract] [Full-text]
41. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.
    Br J Cancer, 91(12): 2063-70. [Abstract] [Full-text]
42. SMAC is expressed de novo in a subset of cervical cancer tumors.
    BMC Cancer, 4: 84. [Abstract] [Full-text]
43. Family physicians' perspectives on practice guidelines related to cancer control.
    BMC Fam Pract, 5: 25. [Abstract] [Full-text]
44. State of the Art Symposium: prescreening and rescreening.
    Cancer, 102(6): 331-3. [Abstract] [Full-text]
45. Identification of progressive cervical epithelial cell abnormalities using DNA image cytometry.
    Cancer, 102(6): 373-9. [Abstract] [Full-text]
46. Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program.
    Cancer, 102(6): 362-7. [Abstract] [Full-text]
47. ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
    Cancer Gene Ther, 12(1): 61-71. [Abstract] [Full-text]
48. Anaplastic (pleomorphic) subtype embryonal rhabdomyosarcoma of the cervix.
    Arch Gynecol Obstet, 270(4): 278-80. [Abstract] [Full-text]
49. Asymptomatic vasculitis of the uterine cervix in presence of cervical intraepithelial neoplasia grade III.
    Arch Gynecol Obstet, 270(4): 294-5. [Abstract] [Full-text]
50. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria.
    Cancer Res, 64(24): 8960-7. [Abstract] [Full-text]
51. MRI of endocervical glandular disorders: three cases of a deep nabothian cyst and three cases of a minimal-deviation adenocarcinoma.
    Magn Reson Imaging, 22(9): 1333-7. [Abstract] [Full-text]
52. Cosine histogram analysis for spectral image data classification.
    Appl Spectrosc, 58(11): 1318-24. [Abstract] [Full-text]
53. Panel of genes transcriptionally up-regulated in squamous cell carcinoma of the cervix identified by representational difference analysis, confirmed by macroarray, and validated by real-time quantitative reverse transcription-PCR.
    Clin Chem, 51(1): 27-34. [Abstract] [Full-text]
54. Histopathological prognostic factors in patients with cervical cancer treated with radical hysterectomy and postoperative radiotherapy.
    Int J Clin Oncol, 9(6): 503-9. [Abstract] [Full-text]
55. Chemoradiotherapy for uterine cancer: current status and perspectives.
    Int J Clin Oncol, 9(6): 458-70. [Abstract] [Full-text]
56. Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women.
    Cancer Lett, 217(2): 191-6. [Abstract] [Full-text]
57. Large loop excision and cold coagulation for management of cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet, 88(1): 38-43. [Abstract] [Full-text]
58. Visual inspection of the cervix with acetic acid for cervical intraepithelial lesions.
    Int J Gynaecol Obstet, 88(1): 25-30. [Abstract] [Full-text]
59. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma.
    Pathol Oncol Res, 10(4): 212-8. [Abstract] [Full-text]
60. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome.
    Cancer, 103(1): 85-91. [Abstract] [Full-text]
61. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Cancer, 103(1): 92-101. [Abstract] [Full-text]
62. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women.
    Int J Cancer, 113(6): 1005-9. [Abstract] [Full-text]
63. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.
    Int J Cancer, 113(6): 951-60. [Abstract] [Full-text]
64. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
    Clin Cancer Res, 10(24): 8405-12. [Abstract] [Full-text]
65. Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.
    J Clin Pathol, 58(1): 61-8. [Abstract] [Full-text]
66. Association of specific genotype and haplotype of p53 gene with cervical cancer in India.
    J Clin Pathol, 58(1): 26-31. [Abstract] [Full-text]
67. Active and passive cigarette smoking and the risk of cervical neoplasia.
    Obstet Gynecol, 105(1): 174-81. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.